B2i Digital's banner
B2i Digital's profile picture

B2i Digital

@b2idigital • 16,974 subscribers

B2i Digital is The Capital Markets Matchmaker℠, connecting investors and public companies through digital marketing, investor conferences, and direct meetings.

Shorts

eXoZymes (eXoZymes) (Nasdaq: EXOZ) CEO Michael Heltzen was featured on Session 20 of the GeneCoda podcast Executive Insights for Life Sciences Innovators, in an episode titled “AI-enabled cell-free biomanufacturing and the future of enzyme engineering,” streamed live on YouTube on April 17. eXoZymes is a B2i Digital (B2i Digital) Featured Company. See their full profile at In the conversation, Heltzen discusses the company’s thesis that producing complex molecules outside living cells can enable greater control, scalability, and speed compared to traditional biologic manufacturing. The discussion also covers how AI is helping identify and optimize enzyme pathways, the strategic considerations involved in building a platform company in today’s capital environment, what differentiates cell-free systems from established synthetic biology approaches, and where cell-free biomanufacturing could create commercial impact across nutraceutical, pharmaceutical, and industrial markets. Watch or listen here: Separately, eXoZymes and Cayman Chemical were featured in a Springwise case study on how the two companies are rethinking chemical manufacturing. The piece focuses on eXoZymes’ work bringing enzyme pathways from biology into the world of chemistry, with Cayman Chemical helping to scale the approach. CCO Damien Perriman is featured in the article. See the eXoZymes summary: eXoZymes is a Los Angeles, California-based biotechnology company that has developed a biomanufacturing platform offering the tools and insights to design, engineer, control, and optimize nature’s own natural processes to produce highly valuable natural products via a commercially scalable, sustainable, and abundant alternative: exozymes. eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. Learn more about eXoZymes Inc. at For investor inquiries, visit and learn about other B2i Digital Featured Companies at Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of EXOZ or any security, and it is not intended to offer any opinion on EXOZ as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete disclosure in the Risks and Disclosures section of

eXoZymes (eXoZymes) (Nasdaq: EXOZ) CEO Michael Heltzen was featured on Session 20 of the GeneCoda podcast Executive Insights for Life Sciences Innovators, in an episode titled “AI-enabled cell-free biomanufacturing and the future of enzyme engineering,” streamed live on YouTube on April 17. eXoZymes is a B2i Digital (B2i Digital) Featured Company. See their full profile at In the conversation, Heltzen discusses the company’s thesis that producing complex molecules outside living cells can enable greater control, scalability, and speed compared to traditional biologic manufacturing. The discussion also covers how AI is helping identify and optimize enzyme pathways, the strategic considerations involved in building a platform company in today’s capital environment, what differentiates cell-free systems from established synthetic biology approaches, and where cell-free biomanufacturing could create commercial impact across nutraceutical, pharmaceutical, and industrial markets. Watch or listen here: Separately, eXoZymes and Cayman Chemical were featured in a Springwise case study on how the two companies are rethinking chemical manufacturing. The piece focuses on eXoZymes’ work bringing enzyme pathways from biology into the world of chemistry, with Cayman Chemical helping to scale the approach. CCO Damien Perriman is featured in the article. See the eXoZymes summary: eXoZymes is a Los Angeles, California-based biotechnology company that has developed a biomanufacturing platform offering the tools and insights to design, engineer, control, and optimize nature’s own natural processes to produce highly valuable natural products via a commercially scalable, sustainable, and abundant alternative: exozymes. eXoZymes is led by an experienced management team including Michael Heltzen, CEO; Damien Perriman, CCO; Dr. Tyler Korman, CSO and Co-founder; Dr. Paul Opgenorth, VP of Development and Co-founder; Fouad Nawaz, VP of Finance; Lasse H. Görlitz, VP of Communications; and Amy Lunzer, Chief of Staff. Learn more about eXoZymes Inc. at For investor inquiries, visit and learn about other B2i Digital Featured Companies at Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted EXOZ stock, in line with B2i Digital’s practice of investing alongside its Featured Companies. This post is not intended to solicit the sale of EXOZ or any security, and it is not intended to offer any opinion on EXOZ as an investment. Conduct your own research and consult with your own professional advisors prior to making any investment decisions. See the complete disclosure in the Risks and Disclosures section of

70,350 views

Videos

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

Bloomberg reported May 6 that Wall Street is preparing billions in upcoming data center IPOs, with Morgan Stanley describing the sector as a multi-year public market theme. Carrier Connect Data Solutions Inc (Carrier Connect Data Solutions Inc.) (TSXV: CCDS | OTCQB: CCDSF) is building a public-market roll-up strategy focused on Tier II/III data centers serving AI companies, enterprises, and service providers. Carrier Connect Data Solutions is a New and Notable company in the B2i Digital (B2i Digital) network. To learn more, visit At a recent Virtual Investor Conferences presentation, Carrier Connect CEO Mark Binns explained the company’s acquisition strategy in plain language: acquire private single-location data centers at lower private-market valuations and consolidate them into a public company platform. “In our first year, we raised or spent about $10 million buying four data centers, and we got a $40 million valuation. It is working perfectly.” Carrier Connect’s current principal markets are Vancouver, Ottawa, Saint John, and Perth. The company operates as a carrier-neutral provider, with systems fully independent and owned outright within leased facilities. The company is led by Mark Binns, CEO; Johan Arnet, CTO; and Mark Alexander, CRO. Discover B2i Digital Featured Companies, Experts, and Conferences at B2i Digital is not a broker-dealer or investment adviser, and content shared here is for informational purposes only and is not investment advice.
2:55
b2idigital's profile picture

Bloomberg reported May 6 that Wall Street is preparing billions in upcoming data center IPOs, with Morgan Stanley describing the sector as a multi-year public market theme. Carrier Connect Data Solutions Inc (Carrier Connect Data Solutions Inc.) (TSXV: CCDS | OTCQB: CCDSF) is building a public-market roll-up strategy focused on Tier II/III data centers serving AI companies, enterprises, and service providers. Carrier Connect Data Solutions is a New and Notable company in the B2i Digital (B2i Digital) network. To learn more, visit At a recent Virtual Investor Conferences presentation, Carrier Connect CEO Mark Binns explained the company’s acquisition strategy in plain language: acquire private single-location data centers at lower private-market valuations and consolidate them into a public company platform. “In our first year, we raised or spent about $10 million buying four data centers, and we got a $40 million valuation. It is working perfectly.” Carrier Connect’s current principal markets are Vancouver, Ottawa, Saint John, and Perth. The company operates as a carrier-neutral provider, with systems fully independent and owned outright within leased facilities. The company is led by Mark Binns, CEO; Johan Arnet, CTO; and Mark Alexander, CRO. Discover B2i Digital Featured Companies, Experts, and Conferences at B2i Digital is not a broker-dealer or investment adviser, and content shared here is for informational purposes only and is not investment advice.

B2i Digital

16,769 views • 2 months ago

No more content to load